Gerald Hladik

Email: gerald_hladik@med.unc.edu
Phone: (919) 966-2561 x255
Fax: (919) 966-4251
Office Location: 7008 Burnett-Womack

Gerald Hladik, MD
Associate Professor of Clinical Medicine; Medical Director, Acute Dialysis Unit

Specialty Areas: Management of acute renal failure; Chronic Kidney Disease; End Stage Renal Disease, including all aspects of dialysis; Medical Education

Chronology: BA: Boston University, 1985;
MD: Boston University, 1989; Resident: University of North Carolina, 1989-92;
Clinical Instructor in Medicine: University of North Carolina, 1992-4; Nephrology Fellow: University of North Carolina, 1994-6; Clinical Assistant Professor of Medicine: University of North Carolina, 1996-2003; Medical Director: UNC Hospitals Acute Dialysis Program, 1996-Present; Medical Director: Carolina Dialysis-Carrboro, 1996-Present; Course Director: Urinary System Course, 1998-2002; Associate Professor of Medicine: University of North Carolina, 2003-2004; Block Director: Urinary Systems Course, 2003-Present

Dr. Hladik’s work centers on managing patients with acute and chronic kidney disease and educating future medical professionals. Currently, he is medical director of both the Acute Dialysis Program at UNC Hospitals, and the Carrboro location of Carolina Dialysis. Hladik’s clinical efforts focus on optimizing clinical outcomes for patients with renal failure through quality improvement initiatives in the inpatient and outpatient arenas. He has a strong interest in teaching complex electrolyte disorders and syndromes of acute and chronic kidney disease to medical students and residents. His teaching excellence has been formally recognized by medical students and graduate medical trainees.

Selected Bibliography:

Joy MS, Denu-Ciocca C, Phillips T, Hogan SL and Hladik GA: Lipids in chronic hemodialysis patients: demographic differences and associations with albumin and homocysteine. J Am Soc Nephrol 10: 245A, 1999.

Joy MS and Hladik GA: Disorders of sodium, water, calcium, and phosphorus. In Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG and Posey LM, ed. Pharmacotherpy: A pathophysiologic approach, 5th ed. New York: McGraw Hill, 953-980, 2002.

Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Results of a randomized dose-ranging, placebo controlled study of lanthanum carbonate for reduction of serum phosphate in chronic renal failure patients receiving hemodialysis. J Am Soc Nephrol 10: 261A, 1999.

Finn WF, Joy MS, Hladik GA, and the Lanthanum Study Group: Safety of an investigational phosphate binder (lanthanum carbonate) in hemodialysis patients. J Am Soc Nephrol 10: 231A, 1999.

Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Yoursi BM, Cohen RM and Coburn JW: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13: 1017-1024, 2002.

Tawney KW, Tawney PJW, Hladik GA, Hogan SL, Moore DT, and Falk RJ: The Life Readiness Program: a rehabilitation program for end-stage renal disease patients on hemodialysis. J Am Soc Nephrol 10: 270A, 1999.

Click here for a list of publications on PubMed.

 

 

Back to Faculty & Staff Profiles Page